Ditchcarbon
  • Contact
  1. Organizations
  2. Roche Holding AG
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
CH
updated 19 days ago

Roche Holding AG

Company website

Roche Holding AG, commonly referred to as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, producing unique products such as targeted therapies and advanced diagnostic tools. The company’s robust portfolio includes well-known medications like Herceptin and Avastin, which have transformed cancer treatment. Roche's dedication to innovation has earned it a prominent market position, consistently ranking among the top pharmaceutical companies globally. Its achievements in personalised healthcare and diagnostics underscore its role as a leader in advancing medical science and improving patient outcomes.

DitchCarbon Score

How does Roche Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

89

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Roche Holding AG's score of 89 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.

93%

Let us know if this data was useful to you

Roche Holding AG's reported carbon emissions

In 2024, Roche Holding AG reported total carbon emissions of approximately 5,500,000,000 kg CO2e, with emissions distributed across various scopes: 245,832,000 kg CO2e (Scope 1), 69,198,000 kg CO2e (Scope 2), and 5,478,525,000 kg CO2e (Scope 3). The previous year, 2023, saw similar figures with total emissions of about 5,978,508,000 kg CO2e, comprising 240,266,000 kg CO2e (Scope 1), 98,480,000 kg CO2e (Scope 2), and 5,978,508,000 kg CO2e (Scope 3). Roche has set ambitious climate commitments, aiming for a 70% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2029, using 2022 as the baseline year. Additionally, the company targets a 22.5% reduction in Scope 3 emissions from fuel- and energy-related activities, waste generated in operations, and business travel within the same timeframe. By 2045, Roche aims to achieve net-zero emissions across its entire value chain, with a long-term goal of reducing Scope 1 and 2 emissions by 90% and Scope 3 emissions by 90% from 2022 levels. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Roche's commitment to sustainable practices within the pharmaceutical sector. The company is also focused on ensuring that 70% of its suppliers by emissions have science-based targets by 2029, further enhancing its sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
249,350,000
000,000,000
000,000,000
Scope 2
114,452,000
00,000,000
00,000,000
Scope 3
6,402,719,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roche Holding AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Roche Holding AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Roche Holding AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Broadcom

US
•
Computer and related services (72)
Updated 14 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated about 18 hours ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Intas

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy